SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.2% of their position (5K shares) of IRADIMED CORP on the open market
Open‑market sale worth $503.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2026ACC: 0001613801-26-000008
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-5K
Net shares
Net seller
$503.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−4.34K
Price / share
$100.54
Trade value
$436.24K
% of position
0.2%
1/26/2026
2.27M→2.26M
Common Stock
Indirect
Shares
−661.00
Price / share
$101.38
Trade value
$67.01K
% of position
0.0%
1/26/2026
2.26M→2.26M
Total
Net shares
−5K
Net value
-$503.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/26/2026 | S · Sale | −4.34K | $100.54 | $436.24K | 0.2% | 2.27M | 2.26M |
| Common Stock Indirect | 1/26/2026 | S · Sale | −661.00 | $101.38 | $67.01K | 0.0% | 2.26M | 2.26M |
| Total | −5K | -$503.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned162.95K
Common Stock
IndirectShares owned2.06M
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 162.95K | Indirect |
| Common Stock | 2.06M | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported